• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$10.43 $0.00 (0.00%)

REAL-TIME: Last trade at

Alnylam Pharmaceuticals, Inc.

NASDAQ:ALNY

Jump to this page for:

Related Resources

Top Analyst Upgrades & Downgrades (ACM, ALNY, BIIB, BP, COF, SNP, CTSH, EA, EPB, ERJ, F, LPX, MFC, M

5/8/2012 by 247wallst

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

5/8/2012 by 247wallst

Alnylam Narrows Loss - Analyst Blog

5/4/2012 by Nasdaq

Unlike March Madness, This ACC Is a Winner

3/30/2012 by DailyFinance

The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach - Press Releases

3/28/2012 by Nasdaq

Encouraging Data on Amgen Candidate - Analyst Blog

3/27/2012 by Nasdaq

Company News for February 15, 2012 - Corporate Summary

2/15/2012 by Nasdaq

US STOCK FUTURES: HOT STOCKS TO WATCH

2/14/2012 by Smart Money

US STOCK FUTURES: HOT STOCKS TO WATCH

2/14/2012 by Smart Money

Alnylam Delivers In-Line Numbers - Analyst Blog

2/13/2012 by Nasdaq

Alnylam Pharmaceuticals Shares Dropped: What You Need to Know

2/10/2012 by DailyFinance

Alnylam Gets New Patent - Analyst Blog

2/1/2012 by Nasdaq

Alnylam to Cut 33% Jobs - Analyst Blog

1/23/2012 by Nasdaq

US STOCK FUTURES: HOT STOCKS TO WATCH

1/20/2012 by Smart Money

Alnylam Down to Neutral - Analyst Blog

1/20/2012 by Nasdaq

Alnylam States Preclinical Data - Analyst Blog

12/30/2011 by Nasdaq

Still Bullish on Alnylam - Analyst Blog

12/7/2011 by Nasdaq

Alnylam Completes Trial Enrollment - Analyst Blog

12/1/2011 by Nasdaq

Alnylam Reveals ALNTTR01 Trial Data - Analyst Blog

11/25/2011 by Nasdaq

Sanofi, Regeneron's Anti-Cholesterol Drug Has Good Test Results

11/10/2011 by Smart Money

Hearty Profits: Companies Racing to Develop the Next Big Cholesterol Drug

8/30/2011 by Nasdaq

Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment

6/7/2011 by Nasdaq

A Simplified ASCO 2011 List for Biotech Investor Research

5/9/2011 by Seeking Alpha

7 Stocks That Might See a Short Squeeze

5/9/2011 by Seeking Alpha

ASCO 2011: Opportunities for Biotech Investor Success and Failure

5/2/2011 by Seeking Alpha

6 Cash Rich Biotech Stocks With Catalysts

4/8/2011 by Seeking Alpha

Battered but Unbroken Biotechs

2/28/2011 by Seeking Alpha

Analyst Calls: AEP, AKS, AMAT, EZCH, FRX, LOPE, MYGN, PNW, ZION ...

2/23/2011 by BloggingStocks

Analyst Calls: BRCD, CREE, DUK, HRL, MOLX, RTN, SPWRA, VCLK, WTW ...

2/18/2011 by BloggingStocks

Biotech’s Top and Bottom 10 From 2010

1/6/2011 by Seeking Alpha

20 Stocks Approaching Lows, Being Dumped by the Smart Money

12/14/2010 by Seeking Alpha

4 Small Caps Likely to Rebound?

12/12/2010 by Seeking Alpha

4 Small Caps That Could Pop

12/10/2010 by Nasdaq

20 Oversold Stocks With Conservative Accounting Practices

12/10/2010 by Seeking Alpha

5 Companies That Are Expected to See Sales Slump in 2011

11/24/2010 by Seeking Alpha

Alnylam Caught Off-Guard by Roche Decision to Drop Alliance

11/21/2010 by Seeking Alpha

Bayer to Cut 4,500 Jobs: Biotech's Latest Tribulations

11/21/2010 by Seeking Alpha

Roche Unveils Welcome Show of Earnings Strength

11/18/2010 by Seeking Alpha

Roche Has Problems but RNA Interference Has More

11/18/2010 by Seeking Alpha

The 25 Most Undervalued Stocks Trading Near 52-Week Lows

11/12/2010 by Seeking Alpha
See More Articles...